{
    "organizations": [],
    "uuid": "2bf1b156f96d138ebde21fbd84f0042a9bc4c6d4",
    "author": "",
    "url": "https://www.reuters.com/article/brief-neutrisci-and-lexaria-bioscience-e/brief-neutrisci-and-lexaria-bioscience-enter-global-licensing-agreement-idUSFWN1QG130",
    "ord_in_thread": 0,
    "title": "BRIEF-NeutriSci And Lexaria Bioscience Enter Global Licensing Agreement",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": " 37 PM / in 6 minutes BRIEF-NeutriSci And Lexaria Bioscience Enter Global Licensing Agreement Reuters Staff Feb 26 (Reuters) - Lexaria Bioscience Corp: * NEUTRISCI AND LEXARIA BIOSCIENCE ENTER GLOBAL LICENSING AGREEMENT * NEUTRISCI INTERNATIONAL INC - ‍CO, LEXARIA BIOSCIENCE REVISED THEIR JV AGREEMENT SUCH THAT CO NOW OWNS 100 PERCENT OF AMBARII TRADE CORPORATION​ * NEUTRISCI INTERNATIONAL - NEUTRISCI WILL CONTINUE DEVELOPMENT AND SALES OF CO‘S PROPRIETARY SUBLINGUAL MOUTH-MELT CONSUMER PRODUCTS * NEUTRISCI - LEXARIA HAS GRANTED TO NEUTRISCI, AN INTELLECTUAL PROPERTY LICENSE AND SUPPLY AGREEMENT FOR MANUFACTURING, SALE OF CBD BASED PRODUCTS​ Source text for Eikon: Further company coverage:",
    "published": "2018-02-26T15:36:00.000+02:00",
    "crawled": "2018-02-26T15:50:37.019+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "pm",
        "minute",
        "lexaria",
        "bioscience",
        "enter",
        "global",
        "licensing",
        "agreement",
        "reuters",
        "staff",
        "feb",
        "reuters",
        "lexaria",
        "bioscience",
        "corp",
        "neutrisci",
        "lexaria",
        "bioscience",
        "enter",
        "global",
        "licensing",
        "agreement",
        "neutrisci",
        "international",
        "inc",
        "lexaria",
        "bioscience",
        "revised",
        "jv",
        "agreement",
        "co",
        "owns",
        "percent",
        "ambarii",
        "trade",
        "neutrisci",
        "international",
        "neutrisci",
        "continue",
        "development",
        "sale",
        "co",
        "proprietary",
        "sublingual",
        "consumer",
        "product",
        "neutrisci",
        "lexaria",
        "granted",
        "neutrisci",
        "intellectual",
        "property",
        "license",
        "supply",
        "agreement",
        "manufacturing",
        "sale",
        "cbd",
        "based",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}